Beta Radiation for Glaucoma Bleb Scarring Prevention

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current glaucoma treatments, such as Minimally Invasive Glaucoma Surgery (MIGS) and trabeculectomy, face limitations due to postoperative scarring that impede fluid drainage, leading to high failure rates of drainage blebs and channels, despite the use of antimetabolites like mitomycin C and 5-fluorouracil, which do not effectively preserve blebs.

Innovation Solution

Applying a therapeutic dose of beta radiation to the target area during or after glaucoma surgery using a radioisotope-based applicator system to inhibit scar formation and fibrogenesis, thereby maintaining functioning blebs and channels, and reducing intraocular pressure.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If glaucoma drainage surgery is performed to reduce intraocular pressure, then fluid drainage is improved, but postoperative scarring develops that impedes drainage and causes bleb failure

Engineering Contradiction:

Improvefluid drainage efficiencyVSAvoidbleb functionality over time

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

Beta radiation is applied during or immediately after surgery to prevent scar formation before it can impede drainage. The radiation inhibits fibroblast proliferation and collagen deposition proactively, preventing the harmful scarring process rather than treating it after it occurs.

Inventive Principle:

Principle #9Preliminary anti-action

Solution Approach 2:

The patent converts the harmful effect of radiation (potential tissue damage) into a beneficial outcome by using controlled beta radiation to specifically target and inhibit pathological scarring processes while preserving normal tissue function and drainage capability.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

2Object-affected harmful factors

If antimetabolites like mitomycin C and 5-fluorouracil are used to prevent scarring, then some scar formation is reduced, but they do not effectively preserve blebs and have significant side effects

Engineering Contradiction:

Improvescar formationVSAvoidbleb preservation

Core Design Contradiction:

Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent replaces chemical antimetabolite treatment with physical beta radiation therapy. This substitution eliminates the need for toxic chemicals while achieving similar or superior anti-scarring effects through controlled radiation that specifically inhibits fibroblast activity and collagen synthesis.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention changes the treatment parameter from chemical concentration (antimetabolites) to physical energy dosage (beta radiation). By controlling radiation dose and duration, the treatment achieves effective scar prevention while minimizing damage to surrounding healthy tissues and preserving bleb function.

Inventive Principle:

Principle #35Parameter changes

3Reliability

If aggressive anti-scarring treatment is applied to maintain bleb function, then scar formation is reduced, but tissue damage and inflammation increase

Engineering Contradiction:

Improvebleb function maintenanceVSAvoidtissue inflammation

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

Beta radiation is applied locally and selectively to the bleb site and surrounding conjunctival tissue where scar formation occurs. The radiation dose is confined to the treatment area, providing targeted anti-scarring effects while sparing distant healthy tissues from damage and inflammation.

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The patent applies a moderate, controlled dose of beta radiation that is sufficient to inhibit scar formation but not excessive enough to cause significant tissue damage. This partial action approach achieves the necessary therapeutic effect while minimizing harmful side effects.

Inventive Principle:

Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The beta radiation treatment effectively reduces scarring and inflammation, enhancing the longevity and functionality of drainage blebs and channels, leading to sustained reduction in intraocular pressure and improved treatment outcomes.

Implementation Method 1

Applying a therapeutic dose of beta radiation to the target area during or after glaucoma surgery using a radioisotope-based applicator system to inhibit scar formation and fibrogenesis

Methodology Applied

Scientific EffectBeta radiation: Radiation

Data Source

PatentUS20230034913A1Methods, systems, and compositions for maintaining functioning drainage blebs associated with foreign bodies

Publication Date: 2023.02.02 QSA GLOBAL INC

AI summary

Methods and systems for applying beta radiation to a treatment area, such as a target area of a bleb, in association with and/or in combination with glaucoma surgery. The methods and systems herein may help achieve and/or maintain a healthy intraocular pressure, maintain functioning blebs and/or drainage holes arising from glaucoma drainage procedures or surgeries, help avoid scar formation or wound reversion, inhibit or reduce fibrogenesis and/or inflammation in the blebs or surrounding areas, etc.